Insider · CIK 0001808895

Coulie Bernard

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001808895

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+256K sh	—	—	256,300
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+206K sh	—	—	206,300
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−206K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+325K sh	—	—	325,000
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−250K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+440K sh	—	—	440,000
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−327K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+147K sh	—	—	146,841
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−256K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−147K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−440K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+327K sh	—	—	327,262
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−325K sh	—	—	0
2026-01-22	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.23M sh	—	—	1,230,000
2026-01-20	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−89.4K sh	$1.28	−$114K	505,601
2025-06-17	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	16,623
2025-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+325K sh	—	—	325,000
2025-01-23	PLRXPLIANT THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+163K sh	—	—	593,017
2025-01-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−52.4K sh	$11.20	−$587K	430,517
2024-07-10	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−38.7K sh	$11.56	−$447K	482,936
2024-07-09	PLRXPLIANT THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+75.6K sh	—	—	521,646
2024-01-23	PLRXPLIANT THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+128K sh	—	—	444,532
2024-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+256K sh	—	—	256,300
2024-01-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−25.7K sh	$17.23	−$443K	316,382
2023-07-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−70.2K sh	$18.01	−$1.26M	342,103
2023-07-14	PLRXPLIANT THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+138K sh	—	—	412,253
2023-06-14	SQZ Biotechnologies CoStock OptionA Award	Director	AAward	+39.9K sh	—	—	39,875
2023-03-30	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−35.3K sh	$26.52	−$937K	274,753
2023-03-29	PLRXPLIANT THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+68.7K sh	—	—	310,092
2023-02-03	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15K sh	—	—	327,262
2023-02-03	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−5,262 sh	$34.08	−$179K	240,112
2023-02-03	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15K sh	$6.22	+$93.3K	255,112
2023-02-03	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−9,738 sh	$33.36	−$325K	245,374
2023-02-02	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15K sh	—	—	342,262
2023-02-02	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15K sh	$6.22	+$93.3K	255,112
2023-02-02	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−13.4K sh	$34.13	−$457K	241,717
2023-02-02	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−1,605 sh	$34.96	−$56.1K	240,112
2023-02-01	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−9,455 sh	$34.15	−$323K	245,657
2023-02-01	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−105 sh	$35.55	−$3,733.254	240,112
2023-02-01	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−5,440 sh	$34.78	−$189K	240,217
2023-02-01	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15K sh	—	—	357,262
2023-02-01	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15K sh	$6.22	+$93.3K	255,112
2023-01-31	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,461 sh	$6.22	+$27.7K	255,112
2023-01-31	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−4,461 sh	—	—	372,262
2023-01-31	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10.5K sh	—	—	146,841
2023-01-31	PLRXPLIANT THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−15K sh	$34.92	−$524K	240,112
2023-01-31	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10.5K sh	$2.08	+$21.9K	250,651
2023-01-30	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15K sh	—	—	157,380

Recent filings

Accepted (ET)
Jun 304
Coulie Bernard0001193125-26-291054
SEC(opens sec.gov)
Apr 174
Coulie Bernard0001746473-26-000053
SEC(opens sec.gov)
Jan 264
Coulie Bernard0001746473-26-000017
SEC(opens sec.gov)
Jan 224
Coulie Bernard0001746473-26-000009
SEC(opens sec.gov)
Jun 204
Coulie Bernard0000950170-25-088620
SEC(opens sec.gov)
Jan 274
Coulie Bernard0001746473-25-000009
SEC(opens sec.gov)

Companies

Address

C/O SEPTERNA, INC. 250 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080